This presentation was provided by Alberto Pepe of Authorea, during the NISO hot topic event "Preprints." The virtual conference was held on April 21, 2021.
This presentation was provided by Leslie McIntosh of Ripeta, during the NISO hot topic event "Preprints." The virtual conference was held on April 21, 2021.
This presentation was provided by Kathryn Funk of the National Library of Medicine, during the NISO hot topic event "Preprints." The virtual conference was held on April 21, 2021.
On the Reproducibility of Science: Unique Identification of Research Resourc...Nicole Vasilevsky
Poster presentation at the Data Information Literacy Symposium at Purdue University in Indiana, Sept. 2013. This study is published here: https://peerj.com/articles/148/
Data Visualization in Biomedical Sciences: More than Meets the EyeNils Gehlenborg
In science, data visualization serves two primary purposes. The first is to explore data sets interactively and the second is to communicate discoveries. However, the requirements for visualizations employed in these activities are very different. Therefore, the software tools used for these purposes are typically disconnected, creating significant challenges for reproducibility and effective communication of discoveries in data-driven biomedical science. In this presentation, I will address how a new approach to creating data visualization tools can connect data analysts and other stakeholders inside and outside the scientific community. I will introduce and demonstrate the "Vistories" approach that was motivated by these question.
Presented at the 5th Cancer Research UK Big Data Analytics Conference on Data Visualization.
Biocuration 2014 - The Resource Identification Initiativemhaendel
The document discusses the Resource Identification Initiative (RII) which aims to improve reproducibility in scientific research by promoting the use of Research Resource Identifiers (RRIDs) in published literature. An experiment analyzing over 800 biological resources across multiple journals found that only about 50% were identifiable. The RII is developing standards and tools to integrate RRIDs into the publishing workflow so that resources are consistently and uniquely identified in a machine-readable way. This could help credit data contributions, enable data reanalysis, and improve reproducibility overall. A pilot project is underway to test the inclusion of RRIDs in publications.
Open Drug Discovery Teams Feature OverviewAlex Clark
This document describes Open Drug Discovery Teams (ODDT), a free mobile app for iOS devices that aggregates open chemistry data from various sources. ODDT allows users to browse topics like rare diseases, endorse or comment on entries, and view chemical structures and reactions. Future developments may include more topics, data sources, and advanced cheminformatics tools. The goal is to facilitate collaboration in open drug discovery and chemistry.
This presentation was provided by Bruce Rosenblum of Atypon, during the NISO hot topic event "Preprints." The virtual conference was held on April 21, 2021.
Wimmics seminar--drug interaction knowledge base, micropublication, open anno...jodischneider
Presentation to the INRIA WIMMICS research group 2014-10-17 about our LISC paper: Using the micropublication ontology and the Open Annotation Data Model to represent evidence within a drug-drug interaction knowledge base:
http://jodischneider.com/pubs/lisc2014.pdf
http://wimmics.inria.fr/seminars
This presentation was provided by Leslie McIntosh of Ripeta, during the NISO hot topic event "Preprints." The virtual conference was held on April 21, 2021.
This presentation was provided by Kathryn Funk of the National Library of Medicine, during the NISO hot topic event "Preprints." The virtual conference was held on April 21, 2021.
On the Reproducibility of Science: Unique Identification of Research Resourc...Nicole Vasilevsky
Poster presentation at the Data Information Literacy Symposium at Purdue University in Indiana, Sept. 2013. This study is published here: https://peerj.com/articles/148/
Data Visualization in Biomedical Sciences: More than Meets the EyeNils Gehlenborg
In science, data visualization serves two primary purposes. The first is to explore data sets interactively and the second is to communicate discoveries. However, the requirements for visualizations employed in these activities are very different. Therefore, the software tools used for these purposes are typically disconnected, creating significant challenges for reproducibility and effective communication of discoveries in data-driven biomedical science. In this presentation, I will address how a new approach to creating data visualization tools can connect data analysts and other stakeholders inside and outside the scientific community. I will introduce and demonstrate the "Vistories" approach that was motivated by these question.
Presented at the 5th Cancer Research UK Big Data Analytics Conference on Data Visualization.
Biocuration 2014 - The Resource Identification Initiativemhaendel
The document discusses the Resource Identification Initiative (RII) which aims to improve reproducibility in scientific research by promoting the use of Research Resource Identifiers (RRIDs) in published literature. An experiment analyzing over 800 biological resources across multiple journals found that only about 50% were identifiable. The RII is developing standards and tools to integrate RRIDs into the publishing workflow so that resources are consistently and uniquely identified in a machine-readable way. This could help credit data contributions, enable data reanalysis, and improve reproducibility overall. A pilot project is underway to test the inclusion of RRIDs in publications.
Open Drug Discovery Teams Feature OverviewAlex Clark
This document describes Open Drug Discovery Teams (ODDT), a free mobile app for iOS devices that aggregates open chemistry data from various sources. ODDT allows users to browse topics like rare diseases, endorse or comment on entries, and view chemical structures and reactions. Future developments may include more topics, data sources, and advanced cheminformatics tools. The goal is to facilitate collaboration in open drug discovery and chemistry.
This presentation was provided by Bruce Rosenblum of Atypon, during the NISO hot topic event "Preprints." The virtual conference was held on April 21, 2021.
Wimmics seminar--drug interaction knowledge base, micropublication, open anno...jodischneider
Presentation to the INRIA WIMMICS research group 2014-10-17 about our LISC paper: Using the micropublication ontology and the Open Annotation Data Model to represent evidence within a drug-drug interaction knowledge base:
http://jodischneider.com/pubs/lisc2014.pdf
http://wimmics.inria.fr/seminars
Charleston 2012: Altmetrics: Analyzing the Value in Scholarly ContentWilliam Gunn
This document discusses altmetrics, which analyze the value of scholarly content beyond traditional citations. It summarizes Mendeley, a company that collects research data from users to provide altmetric measures of impact. Mendeley extracts data from the 2 million user profiles and 300 million documents uploaded to its platform. This data allows for faster and more comprehensive measurement of research impact than citation-based metrics alone. The document argues altmetrics are important to better understand what works in research and to serve all research stakeholders more quickly.
This document discusses why journals should ask authors to include Research Resource Identifiers (RRIDs) in their manuscripts. RRIDs help answer questions about what antibodies, animals, cell lines, or software tools were used in a study and allow others to find papers that used the same resources. The document notes that RRIDs improve reproducibility by making materials and methods more transparent. It also discusses how RRIDs can help identify problematic resources like contaminated cell lines or antibodies that do not work or are no longer available. The document provides examples of journals that now require RRIDs and how compliance is implemented.
Linking assertions to evidence with the MicroPublications ontology WG evidenc...jodischneider
How can we link assertions to evidence in the scientific literature?
Discussion about the MicroPublications ontology (http://purl.org/mp/ & see http://arxiv.org/abs/1305.3506 )
Presented to the WG Evidence Panel of the Addressing PDDI Evidence Gaps project https://sites.google.com/site/ddikrandir/home/wg-evidence-panel
FAIRness and Accountability BioIT 2019 FAIR trackHelena Deus
1. The document discusses fairness and accountability in health care data, specifically addressing expectations versus reality in making data FAIR (Findable, Accessible, Interoperable, Reusable).
2. It notes that for data to be truly FAIR, scientists must be equipped with the proper legal, technological and incentive tools to do so, and there needs to be agreement on what expectations of FAIR mean.
3. The document argues that while FAIR is important, it is not enough for health data - data access and usage policies must also be addressed to ensure appropriate data sharing and protection of privacy.
Using ADAGE for pathway-style analysesCasey Greene
This talk was given at the Simons Institute Network Biology workshop. A video of the talk is available online:
https://www.youtube.com/watch?v=HpXDoMi4YO8
Disease Network is the science that has emerged to diagnose a disease from a network aspect
specifically. Networks are the group that interconnect to each others similarly disease networks are
the one that reveal concelled connection among apparently independent biomedical entities like
physiologic process, signaling receptors, in addition to genetic code, also they prove to exists
intitutive in addition to powerful way to learn/discover or diagnose a disease.Due to these networks,
we can now consume the elderly drugs and its method to learn/discover the new drug
accordingly.Example- Colchicine is used in gout but after repurposing it is also used in mediterranean
fever. This is because there are many factors that affect the body during mediterranean fever and
gout, we know that gout is a form of arthritis that causes pain in joints also mediterranean fever is the
one which is accompanied by pain in joints, therefore colchicine is used as a repurposed drug again.In
repurposing of medicines or drugs we first analyse the change in symptoms and identify the target
organ and accorgingly we produce a drug that is compatible with pharmacokinetics of the body. As
the availablity of transcriptomic,proteomic and metabolomic data sources are increasing day by day it helps in classification of disease .Also there are some networks reffered to as complex networks which can be called as collection of linked junctions/ nodes
Recomendations for infrastructure and incentives for open science, presented to the Research Data Alliance 6th Plenary. Presenter: William Gunn, Director of Scholarly Communications for Mendeley.
Share & Flourish workshop, Leiden, August 2014Varsha Khodiyar
This document discusses how journals can encourage data sharing. It notes that research becomes harder to access as it ages due to broken links and obsolete storage formats. Mandating data archiving at publication is needed. It also discusses open and post-publication peer review where referee reports are made public. Data papers and integrating data fully with research papers can encourage sharing. Recognizing data producers with additional credit and including software and code are other ways journals can promote sharing.
No Boundary Thinking in Bioinformatics Workshop KeynoteCasey Greene
"The bounty of the commons"
In this talk, we explore how public data can become more valuable with reuse. This reuse helps us get to the bottom of cases where we are certain and wrong and helps us ask better questions.
20151018 ORCID UAE workshop - Knowledge E - P Purnell presentationORCID, Inc
This document summarizes Philip Purnell's presentation at an ORCID meeting in Abu Dhabi. It discusses Purnell's background and experience in research, publishing, and scientometrics. It then covers topics like the origins of citation databases, what citations are, how citations have evolved with the Internet, and the uses and limitations of bibliometric indicators like productivity, citations, impact, and journal impact factors. Finally, it discusses ORCID integration with databases like Web of Science and Scopus, as well as normalized article-level indicators and bibliometric indicators more broadly.
The Rutgers CETR is a collaborative public-private partnership between Rutgers University, Rockefeller University, and Cubist Pharmaceuticals. It aims to develop new antibiotics to treat multidrug-resistant bacterial infections by identifying chemical leads, optimizing compounds, and advancing candidates for preclinical evaluation. The CETR will examine therapeutic targets and facilitate various stages of the drug discovery process with the goal of producing optimized lead compounds suitable for testing as antibiotic candidates. It leverages the expertise of project leaders, integrated support cores, and access to facilities like the Rutgers Regional Biocontainment Laboratory.
This document discusses the need for open science due to a reproducibility crisis in many scientific disciplines. It notes that many published findings cannot be replicated and estimates that at least two-thirds of published results in psychology and biomedicine may be incorrect. This represents a credibility crisis that undermines public trust in science. The document argues that adopting practices of open science such as preregistration, open data, and detailed documentation can help address this crisis by reducing biases, enabling replication, and increasing transparency and reproducibility. Open science is presented as a means of improving research quality and accelerating discovery for the benefit of both science and society.
Publishers are caretakers of science. Part of that work is maintaining the integrity of scientific literature. Science builds directly upon past work, so we need to be sure that we are building upon a solid foundation and not faulty research. Publishers need to take an active role in monitoring and tracking faulty, retracted research and its influence. I'm asking publishers to (1) clearly mark retracted papers; (2) alert authors who have already cited a retracted paper; and (3) before publishing an article, check its bibliography for retracted papers.
Retracted papers should be clearly marked everywhere they appear, but today that is not the case. Publishers can also use the CrossRef CrossMark service, which lets readers check for article updates (such as retraction) from a little red ribbon at the top of an article. Checking for citations to retracted articles, and limiting future citations, can help science self-correct by shoring up its foundations.
BioVariance - Pediatric Pharmacogenomics in Drug DiscoveryJosef Scheiber
This slideset gives an overview of pharmacogenomic and pediatric dosing knowledge and various influence factors. Finally it shows an example on how to use this kind of Data within predictive approaches.
The document discusses online resources that can support open drug discovery systems. It outlines how pharmaceutical companies spend billions annually on R&D and how public domain data from sources like literature, patents and databases could provide high value. However, such data is difficult to integrate and navigate due to a lack of standards and interoperability between sources. The Open PHACTS project aims to address this by developing standards to semantically integrate drug discovery data from public and private sources.
Free and open access, transparent assessment and dissemination of research in a fast, shared, collaborative, participative and clear manner for all of society are some of the principles of Open Science. The recognition and adoption of open research practices is growing, including new policies that increase public access to scholarly literature and encourage openness of codes and data sharing for its reproduction. Among these initiatives which are reconfiguring scientific communication, preprints have been consolidating themselves as a promising space for free, open and transparent knowledge, streamlining the editorial process. Preprints are the first formal step in making the manuscripts publicly available before being approved by a journal.
The logics of publishing based on science guiding principles have always been in the decision-making power of the editor. From the choice of referees to the distribution of articles approved in publishing editions, the time management to publish keeping quality, periodicity and celerity regarding feedback on the output was always a challenge to editors. Moreover, this time management becomes an even greater challenge to the publishing process in Brazil, and in some parts of Latin America, whose journals’ management is mainly based on voluntary work. Given this scenario, initiatives that seek to make scientific communication faster and more transparent appear as solutions to the daily difficulties of scientific publishing, such as, for instance, preprints, continuous publication and open peer review.
In view of this new reconfiguration of the editorial process, this panel aims to discuss the panorama of fast and transparent scientific communication, seeking to share experiences that have been developed that respond to the editorial demands on the management of time and quality of the papers published in scientific journals and, particularly, to support the development of the SciELO Program preprints policy.
Syllabus
The challenges of scientific publishing and editorial ethics regarding time management and quality; initiatives for fast research communication; metrics and alternative indicators of scientific visibility; preprints and continuous communication experience in the national and international scenario; editorial dynamics of preprints and its models in the market; the demands of the continuous publication flow; open modalities of peer review: peer-review, open peer-review, and crowd-based peer review; the spaces of fast communication in scholarly social platforms.
Topics for a biology literature review pubricaPubrica
The building block of all academic research activities, regardless of discipline, is to base the work on existing knowledge and link it up. Hence, doing so correctly should be a priority for all academics. However, the task has got more and more complicated. Development of knowledge within the field of business research is growing at a tremendous pace while remaining fragmented and interdisciplinary at the same time.
More information: http://bit.ly/32WQeVz
Why pubrica?
When you order our services, we promise you the following – Plagiarism free, always on Time, outstanding customer support, written to Standard, Unlimited Revisions support and High-quality Subject Matter Experts.
Contact us :
Web: https://pubrica.com/
Blog: https://pubrica.com/academy/
Email: sales@pubrica.com
WhatsApp : +91 9884350006
United Kingdom : +44-1143520021
Charleston 2012: Altmetrics: Analyzing the Value in Scholarly ContentWilliam Gunn
This document discusses altmetrics, which analyze the value of scholarly content beyond traditional citations. It summarizes Mendeley, a company that collects research data from users to provide altmetric measures of impact. Mendeley extracts data from the 2 million user profiles and 300 million documents uploaded to its platform. This data allows for faster and more comprehensive measurement of research impact than citation-based metrics alone. The document argues altmetrics are important to better understand what works in research and to serve all research stakeholders more quickly.
This document discusses why journals should ask authors to include Research Resource Identifiers (RRIDs) in their manuscripts. RRIDs help answer questions about what antibodies, animals, cell lines, or software tools were used in a study and allow others to find papers that used the same resources. The document notes that RRIDs improve reproducibility by making materials and methods more transparent. It also discusses how RRIDs can help identify problematic resources like contaminated cell lines or antibodies that do not work or are no longer available. The document provides examples of journals that now require RRIDs and how compliance is implemented.
Linking assertions to evidence with the MicroPublications ontology WG evidenc...jodischneider
How can we link assertions to evidence in the scientific literature?
Discussion about the MicroPublications ontology (http://purl.org/mp/ & see http://arxiv.org/abs/1305.3506 )
Presented to the WG Evidence Panel of the Addressing PDDI Evidence Gaps project https://sites.google.com/site/ddikrandir/home/wg-evidence-panel
FAIRness and Accountability BioIT 2019 FAIR trackHelena Deus
1. The document discusses fairness and accountability in health care data, specifically addressing expectations versus reality in making data FAIR (Findable, Accessible, Interoperable, Reusable).
2. It notes that for data to be truly FAIR, scientists must be equipped with the proper legal, technological and incentive tools to do so, and there needs to be agreement on what expectations of FAIR mean.
3. The document argues that while FAIR is important, it is not enough for health data - data access and usage policies must also be addressed to ensure appropriate data sharing and protection of privacy.
Using ADAGE for pathway-style analysesCasey Greene
This talk was given at the Simons Institute Network Biology workshop. A video of the talk is available online:
https://www.youtube.com/watch?v=HpXDoMi4YO8
Disease Network is the science that has emerged to diagnose a disease from a network aspect
specifically. Networks are the group that interconnect to each others similarly disease networks are
the one that reveal concelled connection among apparently independent biomedical entities like
physiologic process, signaling receptors, in addition to genetic code, also they prove to exists
intitutive in addition to powerful way to learn/discover or diagnose a disease.Due to these networks,
we can now consume the elderly drugs and its method to learn/discover the new drug
accordingly.Example- Colchicine is used in gout but after repurposing it is also used in mediterranean
fever. This is because there are many factors that affect the body during mediterranean fever and
gout, we know that gout is a form of arthritis that causes pain in joints also mediterranean fever is the
one which is accompanied by pain in joints, therefore colchicine is used as a repurposed drug again.In
repurposing of medicines or drugs we first analyse the change in symptoms and identify the target
organ and accorgingly we produce a drug that is compatible with pharmacokinetics of the body. As
the availablity of transcriptomic,proteomic and metabolomic data sources are increasing day by day it helps in classification of disease .Also there are some networks reffered to as complex networks which can be called as collection of linked junctions/ nodes
Recomendations for infrastructure and incentives for open science, presented to the Research Data Alliance 6th Plenary. Presenter: William Gunn, Director of Scholarly Communications for Mendeley.
Share & Flourish workshop, Leiden, August 2014Varsha Khodiyar
This document discusses how journals can encourage data sharing. It notes that research becomes harder to access as it ages due to broken links and obsolete storage formats. Mandating data archiving at publication is needed. It also discusses open and post-publication peer review where referee reports are made public. Data papers and integrating data fully with research papers can encourage sharing. Recognizing data producers with additional credit and including software and code are other ways journals can promote sharing.
No Boundary Thinking in Bioinformatics Workshop KeynoteCasey Greene
"The bounty of the commons"
In this talk, we explore how public data can become more valuable with reuse. This reuse helps us get to the bottom of cases where we are certain and wrong and helps us ask better questions.
20151018 ORCID UAE workshop - Knowledge E - P Purnell presentationORCID, Inc
This document summarizes Philip Purnell's presentation at an ORCID meeting in Abu Dhabi. It discusses Purnell's background and experience in research, publishing, and scientometrics. It then covers topics like the origins of citation databases, what citations are, how citations have evolved with the Internet, and the uses and limitations of bibliometric indicators like productivity, citations, impact, and journal impact factors. Finally, it discusses ORCID integration with databases like Web of Science and Scopus, as well as normalized article-level indicators and bibliometric indicators more broadly.
The Rutgers CETR is a collaborative public-private partnership between Rutgers University, Rockefeller University, and Cubist Pharmaceuticals. It aims to develop new antibiotics to treat multidrug-resistant bacterial infections by identifying chemical leads, optimizing compounds, and advancing candidates for preclinical evaluation. The CETR will examine therapeutic targets and facilitate various stages of the drug discovery process with the goal of producing optimized lead compounds suitable for testing as antibiotic candidates. It leverages the expertise of project leaders, integrated support cores, and access to facilities like the Rutgers Regional Biocontainment Laboratory.
This document discusses the need for open science due to a reproducibility crisis in many scientific disciplines. It notes that many published findings cannot be replicated and estimates that at least two-thirds of published results in psychology and biomedicine may be incorrect. This represents a credibility crisis that undermines public trust in science. The document argues that adopting practices of open science such as preregistration, open data, and detailed documentation can help address this crisis by reducing biases, enabling replication, and increasing transparency and reproducibility. Open science is presented as a means of improving research quality and accelerating discovery for the benefit of both science and society.
Publishers are caretakers of science. Part of that work is maintaining the integrity of scientific literature. Science builds directly upon past work, so we need to be sure that we are building upon a solid foundation and not faulty research. Publishers need to take an active role in monitoring and tracking faulty, retracted research and its influence. I'm asking publishers to (1) clearly mark retracted papers; (2) alert authors who have already cited a retracted paper; and (3) before publishing an article, check its bibliography for retracted papers.
Retracted papers should be clearly marked everywhere they appear, but today that is not the case. Publishers can also use the CrossRef CrossMark service, which lets readers check for article updates (such as retraction) from a little red ribbon at the top of an article. Checking for citations to retracted articles, and limiting future citations, can help science self-correct by shoring up its foundations.
BioVariance - Pediatric Pharmacogenomics in Drug DiscoveryJosef Scheiber
This slideset gives an overview of pharmacogenomic and pediatric dosing knowledge and various influence factors. Finally it shows an example on how to use this kind of Data within predictive approaches.
The document discusses online resources that can support open drug discovery systems. It outlines how pharmaceutical companies spend billions annually on R&D and how public domain data from sources like literature, patents and databases could provide high value. However, such data is difficult to integrate and navigate due to a lack of standards and interoperability between sources. The Open PHACTS project aims to address this by developing standards to semantically integrate drug discovery data from public and private sources.
Free and open access, transparent assessment and dissemination of research in a fast, shared, collaborative, participative and clear manner for all of society are some of the principles of Open Science. The recognition and adoption of open research practices is growing, including new policies that increase public access to scholarly literature and encourage openness of codes and data sharing for its reproduction. Among these initiatives which are reconfiguring scientific communication, preprints have been consolidating themselves as a promising space for free, open and transparent knowledge, streamlining the editorial process. Preprints are the first formal step in making the manuscripts publicly available before being approved by a journal.
The logics of publishing based on science guiding principles have always been in the decision-making power of the editor. From the choice of referees to the distribution of articles approved in publishing editions, the time management to publish keeping quality, periodicity and celerity regarding feedback on the output was always a challenge to editors. Moreover, this time management becomes an even greater challenge to the publishing process in Brazil, and in some parts of Latin America, whose journals’ management is mainly based on voluntary work. Given this scenario, initiatives that seek to make scientific communication faster and more transparent appear as solutions to the daily difficulties of scientific publishing, such as, for instance, preprints, continuous publication and open peer review.
In view of this new reconfiguration of the editorial process, this panel aims to discuss the panorama of fast and transparent scientific communication, seeking to share experiences that have been developed that respond to the editorial demands on the management of time and quality of the papers published in scientific journals and, particularly, to support the development of the SciELO Program preprints policy.
Syllabus
The challenges of scientific publishing and editorial ethics regarding time management and quality; initiatives for fast research communication; metrics and alternative indicators of scientific visibility; preprints and continuous communication experience in the national and international scenario; editorial dynamics of preprints and its models in the market; the demands of the continuous publication flow; open modalities of peer review: peer-review, open peer-review, and crowd-based peer review; the spaces of fast communication in scholarly social platforms.
Topics for a biology literature review pubricaPubrica
The building block of all academic research activities, regardless of discipline, is to base the work on existing knowledge and link it up. Hence, doing so correctly should be a priority for all academics. However, the task has got more and more complicated. Development of knowledge within the field of business research is growing at a tremendous pace while remaining fragmented and interdisciplinary at the same time.
More information: http://bit.ly/32WQeVz
Why pubrica?
When you order our services, we promise you the following – Plagiarism free, always on Time, outstanding customer support, written to Standard, Unlimited Revisions support and High-quality Subject Matter Experts.
Contact us :
Web: https://pubrica.com/
Blog: https://pubrica.com/academy/
Email: sales@pubrica.com
WhatsApp : +91 9884350006
United Kingdom : +44-1143520021
20 Topics for a Biology Literature Review –PubricaPubrica
The building block of all academic research activities, regardless of discipline, is to base the work on existing knowledge and link it up. Hence, doing so correctly should be a priority for all academics. However, the task has got more and more complicated. Development of knowledge within the field of business research is growing at a tremendous pace while remaining fragmented and interdisciplinary at the same time.
For more details, please visit our website: http://bit.ly/32WQeVz
Why Pubrica?
When you order our services, we promise you the following – Plagiarism free, always on Time, outstanding customer support, written to Standard, Unlimited Revisions support and High-quality Subject Matter Experts.
Reference: literature review writing services
Contact us :
Web: https://pubrica.com/
Blog: https://pubrica.com/academy/
Email: sales@pubrica.com
WhatsApp : +91 9884350006
United Kingdom: +44-1143520021
Microbial infection Point-of-care diagnosticsHaopeng Wang
This document discusses trends in patent filings for point-of-care (POC) diagnostic tests for microbial infections from 2009 to 2013. Key points include:
- The number of patent filings initially increased from 2009 to 2010 but then decreased in subsequent years, likely due to reduced research budgets during the global financial crisis.
- The USA accounts for the majority (78%) of first patent filings in any given patent family for POC diagnostics. The UK is the second most common destination for first filings.
- UK patent applications tend to focus on disposable assay cartridges and broad coverage of any pathogen rather than a specific one, with some targeting bacterial infections.
This document provides a summary of the 2nd edition of the textbook "Basic epidemiology" by R. Bonita, R. Beaglehole, and T. Kjellström. It was published by the World Health Organization in 2006 to strengthen education, training, and research in public health. Since its initial publication in 1993, over 50,000 copies of the textbook have been printed and it has been translated into over 25 languages. The preface describes the scope and uses of epidemiology and provides background on the widespread adoption of the textbook globally.
HealthBIO 2021_Cancer I/O Translating immuno-oncology into health actions_Jer...Business Turku
This document provides a summary of an introduction to cancer immuno-oncology. It discusses utilizing the immune system to kill cancer cells and the increasing uptake of immuno-oncology drugs. It outlines the goals of the Cancer IO Office to facilitate immuno-oncology uptake through strategic foresight, societal discussion, and Finnish immuno-oncology research. The document describes the Cancer IO Office's themes of immuno-oncology in society, research, and healthcare which include developing 3D cancer culture models, utilizing real-world data to identify super responders, and analyzing immuno-oncology uptake in Finnish hospitals.
Brochure Medical Profiling and Online MedicineEuroBioForum
This document provides an overview and analysis of the ethics surrounding medical profiling and online medicine in the context of personalised healthcare. It discusses how developments in testing technologies and increasing access to health information online have the potential to transform healthcare by enabling more predictive, preventive and personalised approaches. However, it notes that the real impact of these technologies is still uncertain and that they raise significant ethical challenges regarding issues like medicalisation, responsibility for health, and implications for public health systems. The document aims to promote public understanding and discussion of these complex issues.
The benefits of patient involvement in research and development (RE:ACT Congr...jangeissler
This document discusses the benefits of patient involvement in health research and development. It notes that innovation is transforming lives but more breakthroughs are still needed. Patients can provide unique perspectives to improve trial design and address unmet needs. However, public distrust and lack of knowledge limit patient participation in research. The document advocates for greater patient involvement at all stages of research, from setting priorities to disseminating results. It highlights the EUPATI initiative which aims to educate patients and the public about medicines research through training courses, educational tools, and national platforms. The goal is empowering patients as partners in research.
This document provides an introduction to the field of epidemiology. It discusses the origins and historical context of epidemiology as a discipline, including key early contributors like John Snow. The document defines epidemiology and outlines its scope and various uses, including investigating disease causation, understanding disease natural history, assessing population health status, and evaluating interventions. It highlights some major achievements of epidemiology in improving public health for diseases like smallpox, methyl mercury poisoning, and HIV/AIDS.
This document is the preface to the second edition of the book "Basic epidemiology" by R. Bonita, R. Beaglehole, and T. Kjellström. It discusses how the first edition of the book has been widely used to strengthen public health education, training, and research around the world since its publication in 1993, with over 50,000 copies printed and translations into over 25 languages. The preface introduces the scope and purpose of the book, which is to define epidemiology, discuss its history and modern applications, and provide instruction on measuring health, disease exposure, and conducting epidemiological studies.
Richard horton Offl ine: What is medicine’s 5 sigma?Anochi.com.
This document summarizes a symposium discussion on reproducibility and reliability issues in biomedical research. The key points are:
1) There is a widespread perception that much of the scientific literature may be untrue due to problems like small sample sizes, questionable research practices, and conflicts of interest.
2) Journals, universities, and research culture also contribute by incentivizing quantity over quality, impact factors, and "sexy" findings over important confirmations.
3) Proposed solutions discussed fixing incentives to reward reliability over productivity, preregistration, collaboration over competition, and adopting standards from fields like particle physics where the bar for a "significant" result is much higher.
4)
What is the future of scientific communication? Open Science (Claude Pirmez)http://bvsalud.org/
Apresentação da Profª Drª Claude Pirmez na Reunião de Editores Científicos do CRICS10, em 04/12/2018
http://crics10.org/eventos/pt/event/reuniao-de-editores-cientificos/
This document discusses the pervasive problem of scientific misconduct in biomedical research. It characterizes some forms of deliberate misconduct like falsifying results and discusses problematic areas like inappropriate data analysis. Scientific progress relies on building upon past work, but misconduct damages trust and hinders honest research. While most published research was once thought to be accurate, today only 10% of biomedical papers can be reproduced due to this growing problem of misconduct. This undermines scientific integrity and wastes public funds supporting biomedical research.
Meeting healthcare challenges: what are the challenges and what is the role o...Mohammad Al-Ubaydli
The document discusses the challenges facing healthcare systems and the role that e-health can play in addressing these challenges. The major challenges are quality and safety, access, responsiveness, and affordability. E-health can help by providing access to electronic patient records, reducing complexity, optimizing information processing, and increasing efficiency. It can also help with navigation through the healthcare system and engaging patients in their own health. The document advocates for free access to research information and using data to identify at-risk patients in need of care.
Colin Mansfield is a British citizen currently working as a Principal Medical Writer and IP Manager in Paris, France. He has over 20 years of experience in medical writing, intellectual property management, and research. His background includes a Ph.D. in Biomedical Physics, M.Sc. in Medical Physics, and B.Sc. in Physics with Astrophysics. He has authored over 25 articles and book chapters, and has received several awards and fellowships for his research work.
Ähnlich wie Pepe "Enriching Preprints with Provenance, Reproducibility, and Trustworthiness" (20)
This presentation was provided by Racquel Jemison, Ph.D., Christina MacLaughlin, Ph.D., and Paulomi Majumder. Ph.D., all of the American Chemical Society, for the second session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session Two: 'Expanding Pathways to Publishing Careers,' was held June 13, 2024.
This presentation was provided by Rebecca Benner, Ph.D., of the American Society of Anesthesiologists, for the second session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session Two: 'Expanding Pathways to Publishing Careers,' was held June 13, 2024.
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, during the closing segment of the NISO training series "AI & Prompt Design." Session Eight: Limitations and Potential Solutions, was held on May 23, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, during the seventh segment of the NISO training series "AI & Prompt Design." Session 7: Open Source Language Models, was held on May 16, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, during the sixth segment of the NISO training series "AI & Prompt Design." Session Six: Text Classification with LLMs, was held on May 9, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, during the fifth segment of the NISO training series "AI & Prompt Design." Session Five: Named Entity Recognition with LLMs, was held on May 2, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, during the fourth segment of the NISO training series "AI & Prompt Design." Session Four: Structured Data and Assistants, was held on April 25, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, during the third segment of the NISO training series "AI & Prompt Design." Session Three: Beginning Conversations, was held on April 18, 2024.
This presentation was provided by Kaveh Bazargan of River Valley Technologies, during the NISO webinar "Sustainability in Publishing." The event was held April 17, 2024.
This presentation was provided by Dana Compton of the American Society of Civil Engineers (ASCE), during the NISO webinar "Sustainability in Publishing." The event was held April 17, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, during the second segment of the NISO training series "AI & Prompt Design." Session Two: Large Language Models, was held on April 11, 2024.
This presentation was provided by Teresa Hazen of the University of Arizona, Geoff Morse of Northwestern University. and Ken Varnum of the University of Michigan, during the Spring ODI Conformance Statement Workshop for Libraries. This event was held on April 9, 2024
This presentation was provided by William Mattingly of the Smithsonian Institution, during the opening segment of the NISO training series "AI & Prompt Design." Session One: Introduction to Machine Learning, was held on April 4, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, for the eight and final session of NISO's 2023 Training Series on Text and Data Mining. Session eight, "Building Data Driven Applications" was held on Thursday, December 7, 2023.
This presentation was provided by William Mattingly of the Smithsonian Institution, for the seventh session of NISO's 2023 Training Series on Text and Data Mining. Session seven, "Vector Databases and Semantic Searching" was held on Thursday, November 30, 2023.
This presentation was provided by William Mattingly of the Smithsonian Institution, for the sixth session of NISO's 2023 Training Series on Text and Data Mining. Session six, "Text Mining Techniques" was held on Thursday, November 16, 2023.
This presentation was provided by William Mattingly of the Smithsonian Institution, for the fifth session of NISO's 2023 Training Series on Text and Data Mining. Session five, "Text Processing for Library Data" was held on Thursday, November 9, 2023.
This presentation was provided by Todd Carpenter, Executive Director, during the NISO webinar on "Strategic Planning." The event was held virtually on November 8, 2023.
Mehr von National Information Standards Organization (NISO) (20)
Leveraging Generative AI to Drive Nonprofit InnovationTechSoup
In this webinar, participants learned how to utilize Generative AI to streamline operations and elevate member engagement. Amazon Web Service experts provided a customer specific use cases and dived into low/no-code tools that are quick and easy to deploy through Amazon Web Service (AWS.)
This presentation includes basic of PCOS their pathology and treatment and also Ayurveda correlation of PCOS and Ayurvedic line of treatment mentioned in classics.
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...Diana Rendina
Librarians are leading the way in creating future-ready citizens – now we need to update our spaces to match. In this session, attendees will get inspiration for transforming their library spaces. You’ll learn how to survey students and patrons, create a focus group, and use design thinking to brainstorm ideas for your space. We’ll discuss budget friendly ways to change your space as well as how to find funding. No matter where you’re at, you’ll find ideas for reimagining your space in this session.
it describes the bony anatomy including the femoral head , acetabulum, labrum . also discusses the capsule , ligaments . muscle that act on the hip joint and the range of motion are outlined. factors affecting hip joint stability and weight transmission through the joint are summarized.
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...PECB
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
How to Make a Field Mandatory in Odoo 17Celine George
In Odoo, making a field required can be done through both Python code and XML views. When you set the required attribute to True in Python code, it makes the field required across all views where it's used. Conversely, when you set the required attribute in XML views, it makes the field required only in the context of that particular view.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
2. Alberto Pepe
Senior Director of Strategy and
Innovation
Former researcher with 30+
publications in scholarly
communication, information
science, computational
astrophysics. First preprint in 2006!
4. In 2020, for each peer reviewed publication
about COVID-19, a preprint was posted
10.6084/m9.figshare.12033672.v18
Preprinting stats (2020)
5. It’s a great reminder of why preprints are
a reason to be cheerful. Disruption isn’t
comfortable, and it takes a lot of
adjustment. But it can, sometimes, lead to
valuable transformations.
-Hilda Bastian
I’m beginning to see the issue with
preprints. Some are absolutely junk
science that would never get into a journal
any of us heard of, yet are widely used to
support theories about how to treat
patients with deadly diseases
-Venk Murthy
6. • Fast and wide dissemination
• No wait time, no paywalls
• Record of priority with DOI
• Rapid evaluation of results,
community feedback
• No “black box” of peer review
• Preprints get cited, i.e. science
moving faster!
• Perception of low quality
• Potential misuse by media,
journalists and the public
• Inconsistent preprint policies
across journals and publishers
Challenges Benefits
11. Under Review in action
2
When manuscript is sent to
reviewers, it is ingested and
posted with DOI
1
Author opts in to Under
Review when submitting
manuscript
3
Status automatically
updated as manuscript goes
through review
4
Paper published, automatic
link toVersion of Record
assigned
12. Health Sciences
Allergy
International Journal of Obstetrics and Gynecology
British Journal of Clinical Pharmacology
British Journal of Pharmacology
Clinical Case Reports
Clinical Otolaryngology
Computational and Systems Oncology
Echocardiography
Influenza and other respiratory viruses
International Journal of Clinical Practice
Journal of Cardiac Surgery
Journal of Cardiovascular Electrophysiology
Journal of Evaluation in Clinical Practice
Pediatric Allergy and Immunology
Pediatric Blood & Cancer
Pediatric Pulmonology
Transboundary and Emerging Diseases
Life Sciences
Advanced Genetics
Biotechnology Journal
Biotechnology and Bioengineering
Clinical & Experimental Immunology
Ecology and Evolution
Ecology Letters
Human Mutation
Hydrological Processes
Land Degradation & Development
Microbiology Open
Natural Sciences
Molecular Ecology Resources
Molecular Ecology
Plant, Cell & Environment
PROTEINS: Structure, Function, and Bioinformatics
Physical Sciences
AIChE Journal
Applied AI Letters
Engineering Reports
Fatigue & Fracture of Engineering
International Journal of Quantum Chemistry
Journal of the American Oil Chemists' Society
Materials & Structures
Mathematical Methods in the Applied Sciences
Natural Sciences
Ecohydrology
River Research and Applications
In 2020: 11K preprints were posted via
Under Review (1.5k aboutCOVID-19)
45 participating journals
Wiley strongly supports the early and open sharing of preprints before (or simultaneous with) submission to a journal. Already, 85% of the journals Wiley publishes will consider publishing manuscripts that have been submitted to a preprint server. We updated our preprint policy in late 2019 to more fully support researchers who want to preprint (no longer differentiating between non-commercial and commercial preprint servers), and the Wiley policy recommendation is that journals should welcome submission of preprints irrespective of where those preprints have been posted.
We think preprints work better with publishers and journals involved, and that preprints will continue to complement traditional journal publishing, adding speed, openness, and faster feedback for researchers.
But things changed with COVID. Significantly.
The early, rapid dissemination that preprints provide has been at the forefront of the COVID pandemic. At a time when literally every day means more lives lost, the research world has moved faster than many would have suspected possible, producing an absolutely staggering level of research output.
According to Dimensions, in 2020 there were 205,909 publications, 38,827 preprints, 7619 clinical trials, 9,309 datasets, 1,919 patents, 5,025 policy documents, and 4,237 grants related to COVID-19. In particular in the early part of the year, preprints were rapidly established as a key part of COVID-19 research efforts, and in the early stages of the pandemic in May, preprints accounted for one quarter of research output.
The figure shown here is from a github repository that has helpful visualizations of COVID preprints over time. From this you can see that across a wide number of preprint servers, at periods there were hundreds of COVID preprints posted PER DAY.
In the last year, journals and research communities have responded with unprecedented and most likely unsustainable levels of rapid peer review and rapid publication – but perhaps the rise in adoption of preprinting might alleviate some of the pressures on the already overstrained peer review system moving forward.
But things changed with COVID. Significantly.
The early, rapid dissemination that preprints provide has been at the forefront of the COVID pandemic. At a time when literally every day means more lives lost, the research world has moved faster than many would have suspected possible, producing an absolutely staggering level of research output.
According to Dimensions, in 2020 there were 205,909 publications, 38,827 preprints, 7619 clinical trials, 9,309 datasets, 1,919 patents, 5,025 policy documents, and 4,237 grants related to COVID-19. In particular in the early part of the year, preprints were rapidly established as a key part of COVID-19 research efforts, and in the early stages of the pandemic in May, preprints accounted for one quarter of research output.
The figure shown here is from a github repository that has helpful visualizations of COVID preprints over time. From this you can see that across a wide number of preprint servers, at periods there were hundreds of COVID preprints posted PER DAY.
In the last year, journals and research communities have responded with unprecedented and most likely unsustainable levels of rapid peer review and rapid publication – but perhaps the rise in adoption of preprinting might alleviate some of the pressures on the already overstrained peer review system moving forward.
Building on the idea of rapid sharing, the explosion of preprints on COVID-19 research has also spurred a lot of debate around the need for fast vs. sure, or the inherent tension between rapid dissemination and rigorous quality control needed for proper peer review. Much of that debate has occurred on Twitter, popular science blogs, and in the lay media. And, there have been some highly publicized retractions and high-profile withdrawals (on preprint servers and in peer-reviewed publications), like the Santa Clara seroprevalence and hydroxychloroquine study capers.
Concerns expressed about the “infodemic” range from the spread of misinformation to fears about the complete undermining of public understanding and trust in science. It’s true that preprints open the box on science, and science is messy. And in the context of a plague, preprints are now receiving a significant amount of global attention. In fact, preliminary (PEER-REVIEWED) research shows that “because of the speed of their release, preprints—rather than peer-reviewed literature in the same topic area—might be driving discourse related to the ongoing COVID-19 outbreak.” All of this science at hyper speed, which then immediately makes its way into the public discourse and impacts public health policy makes it very high stakes.
I am pro-preprint, and my belief is that preprints pose no more threat to the public than peer-reviewed articles – as there are many cases of bad science making it through poor or incomplete peer review. Importantly, for all the breaking research on COVID (both preprint and peer reviewed), we need to remember that much of it will turn out to be unreliable or wrong as the science continues to build on itself over time. That said, preprints do need to be carefully caveated, and we really need to raise the media’s and the public’s understanding of what a preprint is and is not, and what peer review is and does.
Wiley strongly supports the early and open sharing of preprints before (or simultaneous with) submission to a journal. Already, 85% of the journals Wiley publishes will consider publishing manuscripts that have been submitted to a preprint server. We updated our preprint policy in late 2019 to more fully support researchers who want to preprint (no longer differentiating between non-commercial and commercial preprint servers), and the Wiley policy recommendation is that journals should welcome submission of preprints irrespective of where those preprints have been posted.
We think preprints work better with publishers and journals involved, and that preprints will continue to complement traditional journal publishing, adding speed, openness, and faster feedback for researchers.
Wiley strongly supports the early and open sharing of preprints before (or simultaneous with) submission to a journal. Already, 85% of the journals Wiley publishes will consider publishing manuscripts that have been submitted to a preprint server. We updated our preprint policy in late 2019 to more fully support researchers who want to preprint (no longer differentiating between non-commercial and commercial preprint servers), and the Wiley policy recommendation is that journals should welcome submission of preprints irrespective of where those preprints have been posted.
We think preprints work better with publishers and journals involved, and that preprints will continue to complement traditional journal publishing, adding speed, openness, and faster feedback for researchers.
Building on the idea of rapid sharing, the explosion of preprints on COVID-19 research has also spurred a lot of debate around the need for fast vs. sure, or the inherent tension between rapid dissemination and rigorous quality control needed for proper peer review. Much of that debate has occurred on Twitter, popular science blogs, and in the lay media. And, there have been some highly publicized retractions and high-profile withdrawals (on preprint servers and in peer-reviewed publications), like the Santa Clara seroprevalence and hydroxychloroquine study capers.
Concerns expressed about the “infodemic” range from the spread of misinformation to fears about the complete undermining of public understanding and trust in science. It’s true that preprints open the box on science, and science is messy. And in the context of a plague, preprints are now receiving a significant amount of global attention. In fact, preliminary (PEER-REVIEWED) research shows that “because of the speed of their release, preprints—rather than peer-reviewed literature in the same topic area—might be driving discourse related to the ongoing COVID-19 outbreak.” All of this science at hyper speed, which then immediately makes its way into the public discourse and impacts public health policy makes it very high stakes.
I am pro-preprint, and my belief is that preprints pose no more threat to the public than peer-reviewed articles – as there are many cases of bad science making it through poor or incomplete peer review. Importantly, for all the breaking research on COVID (both preprint and peer reviewed), we need to remember that much of it will turn out to be unreliable or wrong as the science continues to build on itself over time. That said, preprints do need to be carefully caveated, and we really need to raise the media’s and the public’s understanding of what a preprint is and is not, and what peer review is and does.
Building on the idea of rapid sharing, the explosion of preprints on COVID-19 research has also spurred a lot of debate around the need for fast vs. sure, or the inherent tension between rapid dissemination and rigorous quality control needed for proper peer review. Much of that debate has occurred on Twitter, popular science blogs, and in the lay media. And, there have been some highly publicized retractions and high-profile withdrawals (on preprint servers and in peer-reviewed publications), like the Santa Clara seroprevalence and hydroxychloroquine study capers.
Concerns expressed about the “infodemic” range from the spread of misinformation to fears about the complete undermining of public understanding and trust in science. It’s true that preprints open the box on science, and science is messy. And in the context of a plague, preprints are now receiving a significant amount of global attention. In fact, preliminary (PEER-REVIEWED) research shows that “because of the speed of their release, preprints—rather than peer-reviewed literature in the same topic area—might be driving discourse related to the ongoing COVID-19 outbreak.” All of this science at hyper speed, which then immediately makes its way into the public discourse and impacts public health policy makes it very high stakes.
I am pro-preprint, and my belief is that preprints pose no more threat to the public than peer-reviewed articles – as there are many cases of bad science making it through poor or incomplete peer review. Importantly, for all the breaking research on COVID (both preprint and peer reviewed), we need to remember that much of it will turn out to be unreliable or wrong as the science continues to build on itself over time. That said, preprints do need to be carefully caveated, and we really need to raise the media’s and the public’s understanding of what a preprint is and is not, and what peer review is and does.
Wiley strongly supports the early and open sharing of preprints before (or simultaneous with) submission to a journal. Already, 85% of the journals Wiley publishes will consider publishing manuscripts that have been submitted to a preprint server. We updated our preprint policy in late 2019 to more fully support researchers who want to preprint (no longer differentiating between non-commercial and commercial preprint servers), and the Wiley policy recommendation is that journals should welcome submission of preprints irrespective of where those preprints have been posted.
We think preprints work better with publishers and journals involved, and that preprints will continue to complement traditional journal publishing, adding speed, openness, and faster feedback for researchers.
Wiley strongly supports the early and open sharing of preprints before (or simultaneous with) submission to a journal. Already, 85% of the journals Wiley publishes will consider publishing manuscripts that have been submitted to a preprint server. We updated our preprint policy in late 2019 to more fully support researchers who want to preprint (no longer differentiating between non-commercial and commercial preprint servers), and the Wiley policy recommendation is that journals should welcome submission of preprints irrespective of where those preprints have been posted.
We think preprints work better with publishers and journals involved, and that preprints will continue to complement traditional journal publishing, adding speed, openness, and faster feedback for researchers.
Wiley strongly supports the early and open sharing of preprints before (or simultaneous with) submission to a journal. Already, 85% of the journals Wiley publishes will consider publishing manuscripts that have been submitted to a preprint server. We updated our preprint policy in late 2019 to more fully support researchers who want to preprint (no longer differentiating between non-commercial and commercial preprint servers), and the Wiley policy recommendation is that journals should welcome submission of preprints irrespective of where those preprints have been posted.
We think preprints work better with publishers and journals involved, and that preprints will continue to complement traditional journal publishing, adding speed, openness, and faster feedback for researchers.
A
Note that the preprint was updated with a link to the version of record automatically.
Note that the preprint was updated with a link to the version of record automatically.
Note that the preprint was updated with a link to the version of record automatically.